Related Experiment Video
Updated: Aug 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders
Jonathan S C Caudill1, Alexander J Sternberg, Chin-Yang Li
1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Abstract:
C-terminal somatic mutations in nucleophosmin (NPM), a nucleolar shuttling protein that binds p53 and p19(Arf), were recently described in karyotypically normal acute myeloid leukaemia (AML). We analysed primary marrow samples from 150 patients with various chronic myeloid disorders for mutations in the NPM1 gene encoding NPM. NPM1 mutations (tetranucleotide duplication) were detected in three patients, all of whom had chronic myelomonocytic leukaemia (CMML) and a short (<1 year) survival, with rapid progression to overt AML. All other patients were NPM1-wild type in the region analysed. In conclusion, C-terminal NPM mutations are uncommon in chronic myeloid neoplasia, but if present may represent an evolving leukaemic clone.
Insights
C-terminal nucleophosmin (NPM) mutations are rare in chronic myeloid disorders. However, their presence in chronic myelomonocytic leukaemia (CMML) may indicate an evolving leukaemic clone with poor prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- C-terminal somatic mutations in nucleophosmin (NPM) are associated with acute myeloid leukaemia (AML).
- NPM is a nucleolar shuttling protein crucial for binding p53 and p19(Arf).
Purpose of the Study:
- To investigate the prevalence and significance of NPM1 mutations in chronic myeloid disorders.
- To determine if NPM1 mutations are associated with specific subtypes or clinical outcomes in these disorders.
Main Methods:
- Analysis of primary marrow samples from 150 patients with various chronic myeloid disorders.
- Detection of mutations in the NPM1 gene, specifically focusing on the C-terminal region.
Main Results:
- NPM1 mutations (tetranucleotide duplication) were identified in three patients with chronic myelomonocytic leukaemia (CMML).
- These patients exhibited a short survival (<1 year) and rapid progression to overt AML.
- The majority of patients with other chronic myeloid disorders were NPM1-wild type in the analyzed region.
Conclusions:
- C-terminal NPM mutations are uncommon in the broader spectrum of chronic myeloid neoplasia.
- The presence of NPM1 mutations in CMML may signify an evolving leukaemic clone with aggressive behavior and poor prognosis.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Related Concept Videos
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Nucleolus